<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2025-4573</article-id><article-id custom-type="edn" pub-id-type="custom">TTBPSD</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-4573</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Мониторинг активности специфических антител к возбудителям инфекционных заболеваний по материалам биобанка</article-title><trans-title-group xml:lang="en"><trans-title>Monitoring the activity of specific antibodies to pathogens based on biobank materials</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8521-1741</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ноздрачева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nozdracheva</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анна Валерьевна Ноздрачева — к.м.н., с.н.с., зав. лабораторией неспецифической профилактики инфекционных заболеваний.</p><p>Ул. Гамалеи, д. 18, 123098, Москва</p></bio><bio xml:lang="en"><p>18 Gamaleya St., Moscow, 123098</p></bio><email xlink:type="simple">nozdracheva0506@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6686-9011</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семененко</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenenko</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Анатольевна Семененко — д.м.н., профессор, г.н.с. отдела эпидемиологии.</p><p>Ул. Гамалеи, д. 18, 123098, Москва</p></bio><bio xml:lang="en"><p>18 Gamaleya St., Moscow, 123098</p></bio><email xlink:type="simple">meddy@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-9953-1761</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермакова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ermakova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Владимировна Ермакова — лаборант-­исследователь отдела эпидемиологии.</p><p>Ул. Гамалеи, д. 18, 123098, Москва</p></bio><bio xml:lang="en"><p>18 Gamaleya St., Moscow, 123098</p></bio><email xlink:type="simple">ermakovat1506@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-3696-4658</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ковтун</surname><given-names>Л. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Kovtun</surname><given-names>L. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Людмила Олеговна Ковтун — лаборант-­исследователь отдела эпидемиологии.</p><p>Ул. Гамалеи, д. 18, 123098, Москва</p></bio><bio xml:lang="en"><p>18 Gamaleya St., Moscow, 123098</p></bio><email xlink:type="simple">kovtunluda12@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Минздрава России</institution></aff><aff xml:lang="en"><institution>Gamaleya National Research Center for Epidemiology and Microbiology</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>01</month><year>2026</year></pub-date><volume>24</volume><issue>11</issue><fpage>4573</fpage><lpage>4573</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ноздрачева А.В., Семененко Т.А., Ермакова Т.В., Ковтун Л.О., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Ноздрачева А.В., Семененко Т.А., Ермакова Т.В., Ковтун Л.О.</copyright-holder><copyright-holder xml:lang="en">Nozdracheva A.V., Semenenko T.A., Ermakova T.V., Kovtun L.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/4573">https://cardiovascular.elpub.ru/jour/article/view/4573</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить влияние температурных режимов хранения (-20 и -70 оC) и длительности экспозиции (6 мес. и 6 лет) на сохранность и стабильность специфических антител класса IgG к HBs-антигену вируса гепатита В (анти-­HBs IgG) в образцах сывороток крови, хранящихся в биобанке.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Проведено экспериментальное исследование 180 образцов сыворотки крови. Уровень анти-­HBs IgG определяли методом иммуноферментного анализа (ИФА) с использованием тест-систем ЗАО "Вектор-­Бест" (Россия) в нативных образцах и после хранения в соответствии с двумя сценариями: 1) хранение при -20 и -70 оС в течение 6 мес.; 2) хранение при -70 оС в течение 6 мес. и 6 лет. Статистический анализ проводили с использованием непараметрических методов (критерий Уилкоксона, медиана, интерквартильный размах, коэффициент корреляции Спирмена).</p></sec><sec><title>Результаты</title><p>Результаты. В исследовании по первому сценарию установлено, что хранение при -20 оС в течение 6 мес. привело к почти 2-кратному увеличению медианного уровня анти-­HBs IgG (с 35,5 (7,8-76,8) до 65,3 (26,0-105,0) МЕ/мл) и появлению 9 ложноположительных результатов. В исследовании по второму сценарию хранение при -70 оС в течение 6 мес. сопровождалось незначительным снижением уровня антител (с 72,5 (27,9-132,0) до 49,3 (4,0-98,4) МЕ/мл) без ложных результатов, а после 6 лет хранения при -70 оС отмечено дальнейшее их снижение до 33,3 (6,15-88,4) МЕ/мл, 2 образца стали ложноотрицательными. Выявлена сильная корреляция между уровнем антител в нативных образцах и после хранения (p=0,97-0,99; p&lt;0,05).</p></sec><sec><title>Заключение</title><p>Заключение. Долгосрочное (до 6 лет) хранение образцов сыворотки крови при температуре -70 оС является надежным и не вносит критических искажений в результаты популяционных серологических исследований распространенности анти-­HBs IgG. Хранение при -20 оС допустимо лишь краткосрочно, т.к. уже через 6 мес. приводит к появлению ложноположительных результатов и завышению среднего уровня антител, что делает его непригодным для биобанкирования.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the effect of storage temperatures (-20 and -70 оC) and exposure duration (6 months and 6 years) on the preservation and stability of specific anti-hepatitis B virus HBs antigen IgG antibodies (anti-­HBs IgG) in serum samples stored in a biobank.</p></sec><sec><title>Material and methods</title><p>Material and methods. An experimental study was conducted on 180 serum samples. Anti-­HBs IgG levels were determined by enzyme-­linked immunosorbent assay (ELISA) using Vector-­Best test systems (Russia) in native samples and after storage according to two following scenarios: 1) storage at -20 and -70 оC for 6 months; 2) storage at -70 оC for 6 months and 6 years. Statistical analysis was performed using nonparametric methods (Wilcoxon test, median, interquartile range, Spearman correlation coefficient).</p></sec><sec><title>Results</title><p>Results. The study using the first scenario found that storage at -20 оC for 6 months led to an almost 2-fold increase in the median anti-­HBs IgG level (from 35,5 (7,8-76,8) to 65,3 (26,0-105,0) IU/ml) and 9 false-­positive results. In the second scenario study, storage at -70 оC for 6 months was accompanied by a slight decrease in antibody levels (from 72,5 (27,9-132,0) to 49,3 (4,0-98,4) IU/ml) without false positive results. After 6 years of storage at -70 оC, a further decrease to 33,3 (6,15-88,4) IU/ml was noted, with 2 samples becoming false negative. A strong correlation was found between antibody levels in native samples and after storage (р=0,97-0,99; p&lt;0,05).</p></sec><sec><title>Conclusion</title><p>Conclusion. Long-term (up to 6 years) storage of serum samples at -70 оC is reliable and does not critically distort the results of population serological studies of anti-­HBs IgG prevalence. Storage at -20 оC is only acceptable for short-term storage, as after just 6 months it leads to false-­positive results and an overestimation of the average antibody level, making it unsuitable for biobanking.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>биобанк</kwd><kwd>хранение образцов сывороток крови</kwd><kwd>сыворотка крови</kwd><kwd>антитела</kwd><kwd>IgG</kwd><kwd>вирусный гепатит В</kwd><kwd>анти-­HBs IgG</kwd><kwd>стабильность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>biobank</kwd><kwd>storage of serum samples</kwd><kwd>blood serum</kwd><kwd>antibo­dies</kwd><kwd>IgG</kwd><kwd>viral hepatitis B</kwd><kwd>anti-­HBs IgG</kwd><kwd>stability</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке Государственного задания Министерства здравоохранения Российской Федерации № 124020100117-9</funding-statement><funding-statement xml:lang="en">The work was supported by the State Assignment of the Ministry of Health of the Russian Federation № 124020100117-9</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Семе­ненко Т. А., Акимкин В. Г. Сероэпидемиологические исследования в системе надзора за вакциноуправляемыми инфекциями. Журнал микробиологии, эпидемиологии и иммунобиологии. 2018;95(2):87-94. doi:10.36233/0372-9311-2018-2-87-94.</mixed-citation><mixed-citation xml:lang="en">Semenenko TA, Akimkin VG. Seroepidemiology in the surveillance of vaccine-­preventable diseases. Journal of microbiology, epi­de­miology and immunobiology. 2018;95(2):87-94. (In Russ.) doi:10.36233/0372-9311-2018-2-87-94.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hörber S, Klein R, Peter A. Effects of Long-­Term Storage on Se­rum Free Light Chain Stability. Clin Lab. 2019;65(5). doi:10.7754/Clin.Lab.2018.181107.</mixed-citation><mixed-citation xml:lang="en">Hörber S, Klein R, Peter A. Effects of Long-­Term Storage on Se­rum Free Light Chain Stability. Clin Lab. 2019;65(5). doi:10.7754/Clin.Lab.2018.181107.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Козлова В. А., Метель­ская В. А., Покровская М. С. и др. Изучение стабильности био­химических маркеров при непрерывном длительном хранении сыворотки крови и при однократном размораживании. Кар­дио­васкулярная терапия и профилактика. 2020;19(6): 2736. doi:10.15829/1728-8800-2020-2736.</mixed-citation><mixed-citation xml:lang="en">Kozlova VA, Metelskaya VA, Pokrovskaya MS, et al. Stability of serum biochemical markers during standard long-term storage and with a single thawing. Cardiovascular Therapy and Pre­ven­tion. 2020;19(6):2736. (In Russ.) doi:10.15829/1728-8800-2020-2736.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hendriks J, Stals C, Versteilen A, et al. Stability studies of bin­ding and functional anti-vaccine antibodies. Bioanalysis. 2014; 6(10):1385-93. doi:10.4155/bio.14.96.</mixed-citation><mixed-citation xml:lang="en">Hendriks J, Stals C, Versteilen A, et al. Stability studies of bin­ding and functional anti-vaccine antibodies. Bioanalysis. 2014; 6(10):1385-93. doi:10.4155/bio.14.96.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Olmeda P, Díaz-­Regañón D, Villaescusa A, et al. Evaluating the stability of antibody titres against Leishmania infantum deter­mined by IFAT in long-term stored canine frozen samples. Parasit Vectors. 2025;18(1):327. doi:10.1186/s13071-025-06982-x.</mixed-citation><mixed-citation xml:lang="en">Olmeda P, Díaz-­Regañón D, Villaescusa A, et al. Evaluating the stability of antibody titres against Leishmania infantum deter­mined by IFAT in long-term stored canine frozen samples. Parasit Vectors. 2025;18(1):327. doi:10.1186/s13071-025-06982-x.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Engelmaier A, Butterweck HA, Weber A. Stability assessment of anti-bacterial antibodies in immunoglobulin G-depleted serum with validated immunoassays. Immunotherapy. 2023;15(17): 1459-76. doi:10.2217/imt-2023-0127.</mixed-citation><mixed-citation xml:lang="en">Engelmaier A, Butterweck HA, Weber A. Stability assessment of anti-bacterial antibodies in immunoglobulin G-depleted serum with validated immunoassays. Immunotherapy. 2023;15(17): 1459-76. doi:10.2217/imt-2023-0127.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Laner-­Plamberger S, Siller A, Lauth W, et al. Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 con­valescent plasma after long-term storage. Vox Sang. 2025; 120(8):784-92. doi:10.1111/vox.70059.</mixed-citation><mixed-citation xml:lang="en">Laner-­Plamberger S, Siller A, Lauth W, et al. Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 con­valescent plasma after long-term storage. Vox Sang. 2025; 120(8):784-92. doi:10.1111/vox.70059.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Shurrab FM, Al-­Sadeq DW, Amanullah F, et al. Effect of multiple freeze-thaw cycles on the detection of anti-­SARS-CoV-2 IgG an­ti­bo­dies. J Med Microbiol. 2021;70(8):001402. doi:10.1099/jmm.0.001402.</mixed-citation><mixed-citation xml:lang="en">Shurrab FM, Al-­Sadeq DW, Amanullah F, et al. Effect of multiple freeze-thaw cycles on the detection of anti-­SARS-CoV-2 IgG an­ti­bo­dies. J Med Microbiol. 2021;70(8):001402. doi:10.1099/jmm.0.001402.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ноздрачева А. В., Семененко Т. А. Оценка надежности результатов серологического мониторинга по материалам биобанка. Кардиоваскулярная терапия и профилактика. 2023; 22(11):3709. doi:10.15829/1728-8800-2023-3709.</mixed-citation><mixed-citation xml:lang="en">Nozdracheva AV, Semenenko TA. Assessment of the reliability of serological monitoring results based on biobank materials. Cardiovascular Therapy and Prevention. 2023;22(11):3709. (In Russ.) doi:10.15829/1728-8800-2023-3709.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ноздрачева А. В., Се­ме­нен­ко Т. А. Влияние длительного хранения образцов сы­во­роток крови в условиях биобанка для проведения попу­ля­ци­онных сероэпидемиологических исследований. Кар­дио­вас­кулярная терапия и профилактика. 2022;21(11):3407. doi:10.15829/1728-8800-2022-3407.</mixed-citation><mixed-citation xml:lang="en">Nozdracheva AV, Semenenko ТA. Influence of long-term sto­ra­ge of blood serum samples in a biobank for population-­ba­sed se­ro­epi­demiologic studies. Cardiovascular Therapy and Pre­ven­tion. 2022;21(11):3407. (In Russ.). doi:10.15829/1728-8800-2022-3407.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Акимкин В. Г., Семененко Т. А., Никитина Г. Ю. и др. Эпи­де­мио­логия гепатитов B и C в лечебно-профилактических учреждениях. Москва, Бионика. 2013. с. 216. ISBN: 978-5-9903962-1-0.</mixed-citation><mixed-citation xml:lang="en">Akimkin VG, Semenenko TA, Nikitina Gyu, et al. Epidemiology of hepatitis B and C in health care institutions. Moscow. 2013. p. 216. (In Russ.) ISBN: 978-5-9903962-1-0.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Tu T, Douglas MW. Hepatitis B Virus Infection: From Diagnostics to Treatments. Viruses. 2020;12(12):1366. doi:10.3390/v12121366.</mixed-citation><mixed-citation xml:lang="en">Tu T, Douglas MW. Hepatitis B Virus Infection: From Diagnostics to Treatments. Viruses. 2020;12(12):1366. doi:10.3390/v12121366.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lin CL, Kao JH. Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection. Clin Mol Hepatol. 2023;29(3):605-22. doi:10.3350/cmh.2022.0342.</mixed-citation><mixed-citation xml:lang="en">Lin CL, Kao JH. Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection. Clin Mol Hepatol. 2023;29(3):605-22. doi:10.3350/cmh.2022.0342.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Qin Y, Liao P. Hepatitis B virus vaccine breakthrough infec­tion: surveillance of S gene mutants of HBV. Acta Virol. 2018; 62(2):115-21. doi:10.4149/av_2018_210.</mixed-citation><mixed-citation xml:lang="en">Qin Y, Liao P. Hepatitis B virus vaccine breakthrough infec­tion: surveillance of S gene mutants of HBV. Acta Virol. 2018; 62(2):115-21. doi:10.4149/av_2018_210.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Баженов А. И., Эльгорт Д. А., Фельдшерова А. А. и др. Выявление антител к мутантным формам HBsAg у лиц, иммунизированных против гепатита В вакцинами разных субтипов. Эпидемиология и вакцинопрофилактика. 2011;5(60):49-53.</mixed-citation><mixed-citation xml:lang="en">Bazhenov AI, Elgort DA, Feldsherova AA, et al. Detection of anti­bodies to mutant forms of HBsAg in persons immunized against hepatitis B with vaccines of different subtypes. Epidemiology and Vaccinal Prevention. 2011;5(60):49-53. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. Screening and Testing for Hepatitis B Virus Infection: CDC Re­com­mendations, 2023. MMWR Recomm Rep. 2023;72(1):1-25. doi:10.15585/mmwr.rr7201a1.</mixed-citation><mixed-citation xml:lang="en">Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. Screening and Testing for Hepatitis B Virus Infection: CDC Re­com­mendations, 2023. MMWR Recomm Rep. 2023;72(1):1-25. doi:10.15585/mmwr.rr7201a1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Кочетова Е. О., Шамшева О. В., Полес­ко И. В. и др. Особенности формирования специфического иммунитета после вакцинации против вирусного гепатита В у детей и лиц молодого возраста. Лечащий врач. 2023; 26(6):7-15. doi:10.51793/OS.2023.26.6.001.</mixed-citation><mixed-citation xml:lang="en">Kochetova EO, Shamsheva OV, Polesko IV, et al. Features of the for­mation of specific immunity after vaccination against viral hepatitis B in children and young people. Lechaschi Vrach. 2023;26(6):7-15. (In Russ.) doi:10.51793/OS.2023.26.6.001.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Семененко Т. А. Иммунный ответ при вакцинации против гепатита В у лиц с иммунодефицитными состояниями. Эпидемиология и вакцинопрофилактика. 2011;1(56):51-8.</mixed-citation><mixed-citation xml:lang="en">Semenenko TA. Immune response after vaccination against hepa­titis B in patients with immunodeficiency. Epidemiology and Vaccinal Prevention. 2011;1(56):51-8. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Marjani A, Alavian SM, Nassiri Toosi M, et al. Hepatitis B virus in­fec­tion after immunization: How serious it is? An updated review. Clin Exp Med. 2025;25(1):113. doi:10.1007/s10238-025-01645-8.</mixed-citation><mixed-citation xml:lang="en">Marjani A, Alavian SM, Nassiri Toosi M, et al. Hepatitis B virus in­fec­tion after immunization: How serious it is? An updated review. Clin Exp Med. 2025;25(1):113. doi:10.1007/s10238-025-01645-8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Соловьев Д. В., Корабельникова М. С., Куд­ряв­це­ва Е. Н. и др. Серологический мониторинг как инди­катор популяционного иммунитета против гепатита В у на­селения Рос­сийской Федерации в 2017-2022гг. Эпи­де­мио­логия и Вак­ци­но­профилактика. 2024;23(5):24-32. doi:10.31631/2073-3046-2024-23-5-24-32.</mixed-citation><mixed-citation xml:lang="en">Soloviev DV, Korabelnikova MS, Kudryavtseva EN, et al. Sero­lo­gical monitoring as an indicator of population immu­nity against he­patitis B in the population of the Russian Federation in 2017–2022. Epidemiology and Vaccinal Prevention. 2024;23(5):24-32. (In Russ.) doi:10.31631/2073-3046-2024-23-5-24-32.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cuhadar S, Koseoglu M, AtayA, Dirican A. The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med. 2013;23(1):70-7. doi:10.11613/bm.2013.009.</mixed-citation><mixed-citation xml:lang="en">Cuhadar S, Koseoglu M, AtayA, Dirican A. The effect of storage time and freeze-thaw cycles on the stability of serum samples. Biochem Med. 2013;23(1):70-7. doi:10.11613/bm.2013.009.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Anisimov SV, Granstrem OK, Meshkov AN, et al. National as­sociation of biobanks and biobanking specialists: new community for promoting biobanking ideas and projects in Russia. Biopreserv Biobank. 2021;19(1):73-82. doi:10.1089/bio.2020.0049.</mixed-citation><mixed-citation xml:lang="en">Anisimov SV, Granstrem OK, Meshkov AN, et al. National as­sociation of biobanks and biobanking specialists: new community for promoting biobanking ideas and projects in Russia. Biopreserv Biobank. 2021;19(1):73-82. doi:10.1089/bio.2020.0049.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Aladawy AI, Elnakib M, Fattah MA, et al. Impact of -20 оC cryo­pre­servation on serum factors from schistosomiasis patients at different storage durations: insights into serum bio-banking. J Pa­rasit Dis. 2025;49(1):162-72. doi:10.1007/s12639-024-01734-7.</mixed-citation><mixed-citation xml:lang="en">Aladawy AI, Elnakib M, Fattah MA, et al. Impact of -20 оC cryo­pre­servation on serum factors from schistosomiasis patients at different storage durations: insights into serum bio-banking. J Pa­rasit Dis. 2025;49(1):162-72. doi:10.1007/s12639-024-01734-7.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Castro AR, Jost HA. Effect of multiple freeze and thaw cycles on the sensitivity of IgG and IgM immunoglobulins in the sera of patients with syphilis. Sex Transm Dis. 2013;40(11):8701. doi:10.1097/OLQ.0000000000000036.</mixed-citation><mixed-citation xml:lang="en">Castro AR, Jost HA. Effect of multiple freeze and thaw cycles on the sensitivity of IgG and IgM immunoglobulins in the sera of patients with syphilis. Sex Transm Dis. 2013;40(11):8701. doi:10.1097/OLQ.0000000000000036.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
